Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Communicable Diseases Intelligence Quarterly Report|April 28, 2006
Invasive pneumococcal disease in Australia, 2004Paul W Roche, Vicki L Krause, Mark Bartlett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 14, 2018
Species of Cryptosporidia Causing Subclinical Infection Associated With Growth Faltering in Rural and Urban Bangladesh: A Birth Cohort StudyKevin L Steiner, Shahnawaz Ahmed, Carol A Gilchrist, et al.
Bone & Joint Open|August 27, 2025
HIP Surgical Techniques to Enhance Rehabilitation (HIPSTER) : a single-centre, double-blind, parallel three-arm, randomized-controlled, superiority trialHolly Whitmore, Alison Smeatham, Siobhan Creanor, et al.
Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.
Implementation Science : IS|February 5, 2017
Pathways for best practice diffusion: the structure of informal relationships in Canada's long-term care sectorJames W Dearing, Amanda M Beacom, Stephanie A Chamberlain, et al.
Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2024
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiencesEmma J Teasdale, Hazel A Everitt, Sarah L Alderson, et al.
Health Technology Assessment (Winchester, England)|October 14, 2024
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCTAlexandra Wright-Hughes, Alexander C Ford, Sarah L Alderson, et al.
Lancet (London, England)|October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C Ford, Alexandra Wright-Hughes, Sarah L Alderson, et al.
Journal of Advanced Nursing|November 21, 2023
Evaluation of a COVID-19 fundamental nursing care guideline versus usual care: The COVID-NURSE cluster randomized controlled trialDavid A Richards, Jess Bollen, Ben Jones, et al.
Pageof 5